HeartSciences (HSCS) Revenue (2021 - 2025)

HeartSciences' (HSCS) quarterly Revenue came in at $2419.0 in Q4 2025, up 27.32% on a QoQ basis from $1900.0 in Q3 2025.

HeartSciences (HSCS) Revenue (2021 - 2025) Analysis & Trends

HeartSciences (HSCS) has 5 years of Revenue data on file, last reported at $2419.0 in Q4 2025.

Quarterly Revenue changed N/A year-over-year to $2419.0 in Q4 2025, while the trailing twelve-month figure through Apr 2026 was $8669.0 (down 54.49% YoY) and the FY2026 annual result came in at $4319.0, down 0.71% from the prior year.
Revenue advanced to $2419.0 in Q4 2025, from $1900.0 in the prior quarter.
In the past five years, Revenue ranged from a high of $14700.0 in Q1 2024 to a low of $1900.0 in Q3 2025.
A 5-year average of $4679.2 and a median of $3550.0 in 2022 frame the typical range for Revenue.
Annual changes were most pronounced in 2022 — Revenue slumped 57.24% — and 2024, when it surged 653.85%.
Tracing HSCS's Revenue over 5 years: stood at $7484.0 in 2021, then tumbled by 57.24% to $3200.0 in 2022, then climbed by 21.88% to $3900.0 in 2023, then soared by 276.92% to $14700.0 in 2024, then slumped by 83.54% to $2419.0 in 2025.
The last three Revenue figures came in at $2419.0 (Q4 2025), $1900.0 (Q3 2025), and $4350.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Abbott Laboratories	199.90 Bn	194.30 Bn	7.27 Bn	12.59 Bn
2	Stryker	130.01 Bn	126.54 Bn	4.50 Bn	6.59 Bn
3	Medtronic	120.53 Bn	111.31 Bn	6.41 Bn	9.81 Bn
4	Boston Scientific	74.77 Bn	74.24 Bn	3.85 Bn	5.44 Bn
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	1.74 Bn
6	Dexcom	34.74 Bn	32.79 Bn	830.00 Mn	1.31 Bn
7	GE HealthCare Technologies	33.78 Bn	31.67 Bn	2.18 Bn	5.30 Bn
8	Koninklijke Philips	26.43 Bn	23.11 Bn	4.55 Bn	9.61 Bn
9	Steris	23.15 Bn	22.67 Bn	684.20 Mn	1.49 Bn
10	HeartSciences	6.43 Mn	4.73 Mn	-	-

Download Data